ETF1 Antikörper
-
- Target Alle ETF1 Antikörper anzeigen
- ETF1 (Eukaryotic Translation Termination Factor 1 (ETF1))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ETF1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- eukaryotic translation termination factor 1
- Isotyp
- IgG
- Top Product
- Discover our top product ETF1 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- ETF1 (Eukaryotic Translation Termination Factor 1 (ETF1))
- Andere Bezeichnung
- ETF1 (ETF1 Produkte)
- Hintergrund
- Synonyms:ERF1, RF1, SUP45L1 Background:Directs the termination of nascent peptide synthesis(translation) in response to the termination codons UAA, UAG and UGA. Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay(NMD) of mRNAs containing premature stop codons.
- Molekulargewicht
- 45-48kd
- Gen-ID
- 2107
- UniProt
- P62495
-